This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Centre Hospitalier Régional Et Universitaire De Brest, National Institute of Health and Medical Research, Universite De Bretagne Occidentale (Ubo). Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 1,853 
1 out of 4 Years Active: 2022
Title: Marjolaine Debant: Innovator in Medical Diagnostics
Introduction
Marjolaine Debant is a prominent inventor based in Brest, France. She has made significant contributions to the field of medical diagnostics, particularly in the diagnosis and monitoring of chronic lymphoid leukaemia (CLL) and systemic lupus erythematosus (SLE). Her innovative work has led to the development of a patented process that enhances the understanding and management of these complex diseases.
Latest Patents
Marjolaine Debant holds a patent for "Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1." This patent outlines methods for the in vitro detection of the STIM1 protein's expression at the cell plasma membrane in biological samples from humans and mice. The processes described in her patent aim to improve the diagnosis and monitoring of CLL and SLE, providing valuable tools for healthcare professionals.
Career Highlights
Throughout her career, Marjolaine has worked with esteemed institutions, including the Université de Bretagne Occidentale and the Institut National de la Santé et de la Recherche Médicale. Her research has focused on advancing the understanding of autoimmune diseases and blood cancers, contributing to the scientific community's knowledge in these areas.
Collaborations
Marjolaine has collaborated with notable colleagues, including Yves Renaudineau and Olivier Mignen. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in medical diagnostics.
Conclusion
Marjolaine Debant's work exemplifies the impact of innovation in the medical field. Her patented processes for diagnosing and monitoring chronic lymphoid leukaemia and systemic lupus erythematosus represent a significant advancement in healthcare. Through her research and collaborations, she continues to contribute to the improvement of patient outcomes in these challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile